How Value-based Care Could Affect Specialty Pharmacy

Video

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.

Grant E. Knowles, PharmD, vice president of Business Development at Ardon Health, discusses the potential impact of value-based care on specialty pharmacy.

Related Videos
Semaglutide Ozempic injection control blood sugar levels | Image Credit: myskin - stock.adobe.com
Image credit: motortion | stock.adobe.com - Young depressed woman talking to lady psychologist during session, mental health
Image credit: Sergey | stock.adobe.com - Unhappy woman with insomnia lying on bed next to alarm clock at night
Image credit: Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit: JPC-PROD | stock.adobe.com - Choosing method of contraception : Birth control pills, an injection syringe, condom, IUD-method, on grey
Image credit: сергей костюченко | stock.adobe.com - human head with brain
Image credit: photoopus | stock.adobe.com Borderline personality disorder (BPD) Mental Illness. Banner and Concept Image.
Related Content
Medically accurate illustration of a womans large intestine | Image Credit: Sebastian Kaulitzki - stock.adobe.com

Study Finds No Differences Between Adalimumab, Biosimilar for Inflammatory Bowel Disease

April 15th 2024
Article
Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

Pharmacy Focus: Policy Edition - Discussing the DRUG Act and PBM Reform

April 5th 2024
Podcast
Eye monitoring and treatment in medical | Image Credit: maxsim - stock.adobe.com

Biosimilars in Retina Space Expected to Grow in 2024, Coming Years

April 10th 2024
Article
Pharmacy Focus: OTC Contraception and Reproductive Health

Pharmacy Focus: OTC Contraception and Reproductive Health

March 29th 2024
Podcast
FDA approval seal -- Image credit: Aquir | stock.adobe.com

FDA Approves Dolutegravir/Lamivudine for Treatment of Adolescents With HIV-1 Infection

April 8th 2024
Article
Abnormal plasma cell or b-cell in multiple myeloma emitting paraprotein | Image Credit: LASZLO - stock.adobe.com

FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy

April 5th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.